The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents
Abstract
Aims Medication non‐adherence is particularly common in patients with Type 2 diabetes. We constructed a discrete‐choice experiment to examine the relative importance of oral glucose‐lowering medication features and to estimate the likely effect of effectiveness and side effects on medication adherence in patients with Type 2 diabetes in the UK and the USA. Methods Preferences were elicited using a cross‐sectional, web‐enabled survey. Patients with a self‐reported physician‐made diagnosis of Type 2 diabetes, who were currently taking oral glucose‐lowering medications were recruited through an existing online chronic‐disease panel. In each discrete‐choice question, patients were asked to choose between two hypothetical medication alternatives, each defined by improvement in glycated haemoglobin, frequency of mild‐to‐moderate hypoglycaemia, water retention, weight gain, mild stomach upset and medication‐related cardiovascular risk. Patients were also asked to indicate how likely they would be to miss or skip doses of each hypothetical medication. Results Two hundred and four patients in the UK and 203 patients in the USA completed the survey. Preferences did not differ between the two countries. Overall, glucose control was the most important medication feature, followed by medication‐related cardiovascular risk and weight gain, respectively. Water retention was not important to patients. Weight gain and cardiovascular risk had significant negative effects on likely medication adherence. Conclusions While patients with Type 2 diabetes believe glucose control is important, medication side effects and risks influence patients’ treatment choices. Medication‐related weight gain and cardiovascular risk are significant predictors of likely medication non‐adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
Factors That Affect Adherence to Bipolar Disorder Treatments: A Stated-Preference Approach
Johnson, F. R., Özdemir, S., Manjunath, R., Hauber, A. B., Burch, S. P., & Thompson, T. R. (2007) · Medical Care · doi:10.1097/mlr.0b013e318040ad90 · Cited by 164
Self-citation
Cited by
Discrete Choice Experiments in Health Economics: A Review of the Literature
Clark, M. D., Determann, D., Petrou, S., Moro, D., & de Bekker-Grob, E. W. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0170-x · Cited by 851
Adherence to Therapies in Patients with Type 2 Diabetes
García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0034-y · Cited by 726
Roden, M., Weng, J., Eilbracht, J., Delafont, B., Kim, G., Woerle, H. J., & Broedl, U. C. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70084-6 · Cited by 450
Ridderstråle, M., Andersen, K. R., Zeller, C., Kim, G., Woerle, H. J., & Broedl, U. C. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70120-2 · Cited by 378
Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes
Häring, H.-U., Merker, L., Seewaldt-Becker, E., Weimer, M., Meinicke, T., Woerle, H. J., Broedl, U. C., & on behalf of the EMPA-REG METSU Trial Investigators (2013) · Diabetes Care · doi:10.2337/dc12-2673 · Cited by 371
Metadata
- Authors
- Hauber, A. B., Mohamed, A. F., Johnson, F. R., & Falvey, H.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2009-04
- Volume
- 26
- Issue
- 4
- Pages
- 416-424
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2086588588
- Cited by
- 160
- References
- 3
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents. https://app.cochat.ai/papers/10.1111/j.1464-5491.2009.02696.x
- The paper
- Hauber, A. B., Mohamed, A. F., Johnson, F. R., & Falvey, H. (2009). Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2009.02696.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.